LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 204 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $692,076 | -16.9% | 11,550 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $832,755 | +6.9% | 11,550 | +9.1% | 0.00% | 0.0% |
| Q1 2023 | $779,074 | +99781.3% | 10,591 | -9.4% | 0.00% | -25.0% |
| Q4 2022 | $780 | -22.5% | 11,684 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $1,006 | -99.9% | 11,684 | +6.3% | 0.01% | 0.0% |
| Q2 2022 | $980,000 | -21.2% | 10,988 | -0.6% | 0.01% | 0.0% |
| Q1 2022 | $1,244,000 | -13.4% | 11,057 | +18.9% | 0.01% | 0.0% |
| Q4 2021 | $1,437,000 | +8.7% | 9,300 | -1.9% | 0.01% | 0.0% |
| Q3 2021 | $1,322,000 | +48.9% | 9,480 | +40.0% | 0.01% | +66.7% |
| Q2 2021 | $888,000 | -14.0% | 6,770 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $1,032,000 | +41.6% | 6,770 | -7.7% | 0.00% | +33.3% |
| Q4 2020 | $729,000 | -71.7% | 7,331 | -72.8% | 0.00% | -75.0% |
| Q3 2020 | $2,574,000 | -14.8% | 27,000 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $3,020,000 | +42.9% | 27,000 | +45.8% | 0.02% | +50.0% |
| Q2 2019 | $2,114,000 | -16.8% | 18,522 | -8.3% | 0.01% | -23.1% |
| Q1 2019 | $2,540,000 | -7.4% | 20,203 | 0.0% | 0.01% | -13.3% |
| Q4 2018 | $2,742,000 | -27.8% | 20,203 | +46.1% | 0.02% | -16.7% |
| Q3 2018 | $3,796,000 | +27.4% | 13,830 | -3.9% | 0.02% | +20.0% |
| Q2 2018 | $2,980,000 | +21.2% | 14,385 | -3.4% | 0.02% | +15.4% |
| Q1 2018 | $2,459,000 | +9.1% | 14,888 | -9.5% | 0.01% | +30.0% |
| Q4 2017 | $2,253,000 | -1.2% | 16,452 | -1.8% | 0.01% | -16.7% |
| Q3 2017 | $2,281,000 | +5.5% | 16,752 | -5.9% | 0.01% | +20.0% |
| Q2 2017 | $2,162,000 | +14.7% | 17,811 | 0.0% | 0.01% | +11.1% |
| Q1 2017 | $1,885,000 | +22.6% | 17,811 | +17.8% | 0.01% | +12.5% |
| Q4 2016 | $1,537,000 | -0.4% | 15,123 | 0.0% | 0.01% | +14.3% |
| Q3 2016 | $1,543,000 | -9.8% | 15,123 | +5.5% | 0.01% | -22.2% |
| Q2 2016 | $1,710,000 | +11.4% | 14,338 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $1,535,000 | +1.1% | 14,338 | +2.4% | 0.01% | 0.0% |
| Q4 2015 | $1,518,000 | +7.4% | 14,000 | 0.0% | 0.01% | +12.5% |
| Q2 2015 | $1,413,000 | +29.0% | 14,000 | -1.4% | 0.01% | +33.3% |
| Q1 2015 | $1,095,000 | +39.0% | 14,200 | -4.1% | 0.01% | +50.0% |
| Q4 2014 | $788,000 | – | 14,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |